Literature DB >> 21955791

Patient preferences and willingness to pay for arthroplasty surgery in patients with osteoarthritis of the hip.

Kevin J Bozic1, Vanessa Chiu, James D Slover, Igor Immerman, James G Kahn.   

Abstract

Little is known about the economic value patients place on effective treatment of osteoarthritis (OA) of the hip. The purpose of this study was to evaluate the value of total hip arthroplasty (THA) and hip resurfacing arthroplasty (HRA) to patients with advanced hip OA by measuring their preferences and willingness to pay (WTP) for either procedure. Seventy-three patients younger than 65 years with advanced hip OA reviewed information about the risks and benefits of THA and HRA and were asked which procedure they would choose and how much they would be willing to pay for it. Sixty-nine percent of patients chose THA (average WTP, $69 419) and 31% chose HRA (average WTP, $83 195). There was no correlation between WTP and annual income or total assets. However, patients with modest income and assets could have reported that they were willing and able to pay more than they could actually afford, and WTP dropped and correlation with income rose if we excluded high responses from the poorest respondents. These results may have important policy implications as patients are asked to share a greater burden of the cost of their care for chronic conditions such as OA. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21955791     DOI: 10.1016/j.arth.2011.07.007

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  9 in total

Review 1.  Current status of cost utility analyses in total joint arthroplasty: a systematic review.

Authors:  Benedict U Nwachukwu; Kevin J Bozic; William W Schairer; Jaime L Bernstein; David S Jevsevar; Robert G Marx; Douglas E Padgett
Journal:  Clin Orthop Relat Res       Date:  2014-09-30       Impact factor: 4.176

2.  Hip Replacement or Hip Resurfacing with a Highly Cross-Linked Polyethylene Acetabular Bearing: A Qualitative and Quantitative Preference Study.

Authors:  James W Pritchett
Journal:  JB JS Open Access       Date:  2020-05-11

3.  Patients report improvement in quality of life and satisfaction after hip resurfacing arthroplasty.

Authors:  Wael A Rahman; Nelson V Greidanus; Alexander Siegmeth; Bassam A Masri; Clive P Duncan; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2013-02       Impact factor: 4.176

4.  Understanding preferences for disease-modifying drugs in osteoarthritis.

Authors:  Liana Fraenkel; Lisa Suter; Charles E Cunningham; Gillian Hawker
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-08       Impact factor: 4.794

5.  Are patients willing to pay for total shoulder arthroplasty? Evidence from a discrete choice experiment.

Authors:  Nathan N O'Hara; Gerard P Slobogean; Tima Mohammadi; Carlo A Marra; Milena R Vicente; Amir Khakban; Michael D McKee
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

Review 6.  Contingent Valuation Studies in Orthopaedic Surgery: A Health Economic Review.

Authors:  Benedict U Nwachukwu; Claire D Eliasberg; Kamran S Hamid; Michael C Fu; Bernard R Bach; Answorth A Allen; Todd J Albert
Journal:  HSS J       Date:  2018-04-09

7.  Assessing the Patient-Perceived Monetary Value of Patient-Reported Outcome Improvement for Patients With Chronic Knee Conditions.

Authors:  Sarah B Floyd; Alicia Oostdyk; Melanie Cozad; John M Brooks; Paul Siffri; Brian Burnikel
Journal:  J Patient Cent Res Rev       Date:  2021-04-19

8.  Patient risk taking and spending habits correlate with willingness to pay for novel total joint arthroplasty implants.

Authors:  Ran Schwarzkopf; Timothy L Kahn
Journal:  Arthroplast Today       Date:  2015-03-20

9.  Patient Preferences Regarding Surgical Interventions for Knee Osteoarthritis.

Authors:  Claude T Moorman; Tom Kirwan; Jennifer Share; Christopher Vannabouathong
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2017-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.